Clinical Trials Directory

Trials / Completed

CompletedNCT02502630

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

CT-guided Percutaneous Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
The First People's Hospital of Changzhou · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

(MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.

Detailed description

From June 2010 to June 2015, 48 unresectable lesions in 32 patients with pulmonary metastases from colorectal cancer were selected for CT-guided microwave ablation. Patients were scheduled for a 1 and 3 month CT follow-up to evaluate lesion diameter.We retrospectively evaluated CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.

Conditions

Interventions

TypeNameDescription
DEVICEmicrowave ablationpulmonary metastases from colorectal cancer are destructed/ablated using microwave ablation

Timeline

Start date
2010-06-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2015-07-20
Last updated
2016-08-15

Source: ClinicalTrials.gov record NCT02502630. Inclusion in this directory is not an endorsement.